• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril
 

Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril

Options
  • Details
BORIS DOI
10.7892/boris.18673
Date of Publication
2006
Publication Type
Article
Division/Institute

Institut für Parasito...

Author
Haerdi, Corinne
Haessig, Michael
Sager, Heinz
Institut für Parasitologie der Universität Bern
Greif, Gisela
Staubli, Daniela
Institut für Parasitologie der Universität Bern
Gottstein, Brunoorcid-logo
Institut für Parasitologie (IPA)
Subject(s)

600 - Technology::630...

Series
Parasitology research
ISSN or ISBN (if monograph)
0932-0113
Publisher
Springer-Verlag
Language
English
Publisher DOI
10.1007/s00436-006-0199-7
PubMed ID
16628455
Description
Neospora caninum is widely recognized as one of the most important infectious organisms causing abortion and stillbirth in cattle. This parasite causes severe economical losses worldwide. Infection is mostly passed vertically from mother to calf during pregnancy. Under certain circumstances, an infection can lead to abortion, but in most cases it results in a chronically infected calf, which itself will represent the next endogenously infectious generation. So far, no reliable therapeutic or metaphylactic tool has been developed. One possibility to control the problem may consist of treating newborn calves that became vertically infected by a persistently infected mother. This may allow parasite-free offspring. The aim of the present study was to address the questions: (1) can serology be used to assess efficiency of treatment in toltrazuril-medicated animals? and (2) is a strategic prevention measure possible by means of producing N. caninum-free calves from positive cows? Calves from Neospora-seropositive cows and heifers were randomly split into two different medication groups: 36 calves were medicated with toltrazuril and 36 calves obtained a placebo. Medication (20 mg toltrazuril per kg bw) was administered three times, every second day, within the 7 days post natum. Three months after medication, there was no difference in antibody reactivity between the two groups. At later time points (4-6 months), however, significant differences were found, as explained by a strong humoral immunity after chemotherapeutical affection of parasites, while the placebo-treated animals only responded weakly to the persistent infection. In summary, we concluded that (1) serology was not an entirely appropriate tool to answer our initial question and (2) toltrazuril has the potential to eliminate N. caninum in newborn calves. As a consequence, we plan to follow up toltrazuril-medicated calves clinically and serologically over a longer period and investigate if they give birth to Neospora-free calves.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/92466
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
436_2006_Article_199.pdftextAdobe PDF147.92 KBpublisherpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo